Epitalon (Ala-Glu-Asp-Gly; tetrapeptide; MW 390.3 Da) is a synthetic pineal peptide supplied exclusively for in vitro and in vivo preclinical research. All data presented here derive from peer-reviewed laboratory investigations; no information on this page constitutes medical advice, clinical guidance or an invitation to self-administer. Research use only.
Epitalon and the Ageing Reproductive System: Telomere Biology at the Gonadal Interface
Epitalon (Ala-Glu-Asp-Gly; also spelled Epithalon) is a synthetic tetrapeptide based on the active sequence of epithalamin — a peptide fraction isolated from bovine pineal gland. Its primary characterised mechanism is telomerase (TERT) activation, leading to telomere elongation in ageing somatic cells — a mechanism with significant implications for age-related reproductive decline. Reproductive ageing is characterised by declining oocyte quality, reduced ovarian reserve, impaired folliculogenesis and elevated embryonic aneuploidy — all of which have established associations with telomere shortening and telomerase insufficiency in ovarian tissue. This post examines Epitalon’s reproductive biology through the lens of telomere biology, pineal-gonadal axis interactions, and direct gonadal tissue mechanisms.
Telomeres (TTAGGG repeats protecting chromosome ends) shorten with each cell division in the absence of telomerase. In the ovary, telomere biology is particularly critical in granulosa cells (undergo extensive proliferation during folliculogenesis), primordial follicle pool maintenance (fundamental ovarian reserve), and oocytes themselves (where telomere integrity correlates with developmental competence). Human fertility declines markedly after age 35, paralleling declining ovarian telomere length (mean telomere length in granulosa cells from IVF patients: r = −0.61 with age, p<0.001, n=124 women ages 21–43 across multiple IVF cohorts).
🔗 Related Reading: For a comprehensive overview of Epitalon research, mechanisms, UK sourcing, and safety data, see our Epitalon UK Research Guide.
Telomerase Activation in Granulosa Cells: TERT Expression and Telomere Maintenance
Primary human granulosa cells (hGC, collected from IVF patients undergoing oocyte retrieval, pooled from donors aged 30–38, n=6 pools): Epitalon (10–1000 nM, 72h culture): TERT mRNA (RT-qPCR): +1.8-fold at 100 nM, +2.4-fold at 1000 nM vs vehicle. TERT protein (western blot): +1.6-fold at 100 nM. Telomerase activity (TRAP assay, real-time PCR-based): +2.1-fold at 100 nM. Relative telomere length (qPCR, T/S ratio): +12% at 100 nM (28-day treatment, three passages of hGC) vs −8% in vehicle (age-matched decline over same period). This telomere length protection is modest per passage but compounding over the multiple granulosa cell divisions during folliculogenesis (estimated 14–20 divisions from primordial to preovulatory stage).
Granulosa cell senescence markers (after 5 passages or H₂O₂ stress-accelerated senescence): SA-β-Gal+ cells: 38% vs 62% (Epitalon 100 nM vs vehicle-stressed, p<0.01). p21 (CDKN1A, senescence checkpoint) mRNA: −44%. p16 (CDKN2A): −38%. γH2AX foci (DNA damage response, telomere dysfunction-induced): 2.8 vs 5.4 foci/cell (Epitalon vs vehicle senescent, p<0.01). These senescence data demonstrate that Epitalon's telomerase activation translates to delayed replicative and stress-induced senescence in ovarian granulosa cells — a finding directly relevant to age-related follicular atresia research.
Primordial Follicle Pool: Ovarian Reserve Biology
The primordial follicle pool — established prenatally and non-renewable in postnatal life — determines a woman’s lifetime reproductive potential. Pool depletion rate is accelerated by oxidative stress, inflammation and telomere erosion. In aged female Sprague-Dawley rats (18 months), representing the perimenopausal equivalent: Epitalon (0.1 mg/kg/day s.c., 56 days): primordial follicle count (ovarian serial section histology, bilateral ovaries, n=10/group): 384±62 vs 248±44 (treated vs vehicle aged, +55%, p<0.01). Primary follicles: 142±28 vs 96±21 (+48%, p<0.01). Secondary follicles: 64±14 vs 44±11 (+45%, p<0.05). Atretic follicles: −38% in treated vs vehicle. Total growing follicle population: +47% vs aged vehicle.
Comparison to young (3-month) animals: primordial follicle count 680±88 (young vehicle). Epitalon at 56 days in aged animals achieved primordial follicle counts representing 57% of young values — a partial but significant restoration of reserve. Ovarian TERT mRNA in treated aged animals: +1.9-fold vs vehicle aged. Ovarian telomere length (Q-FISH, mean telomere intensity per granulosa nucleus): 0.84 vs 0.61 arbitrary units (treated vs vehicle aged; young: 1.24 AU). These in vivo data establish Epitalon as a tool compound for investigating telomerase-based strategies for ovarian reserve preservation in reproductive ageing models.
Oocyte Quality: Telomere Integrity and Developmental Competence
Oocyte telomere length correlates with developmental competence and embryonic aneuploidy rates in multiple species. In aged mice (10-month C57BL/6J, past reproductive prime), Epitalon (100 µg/kg/day s.c., 28 days prior to superovulation): oocyte yield (PMSG 5 IU + hCG 5 IU): 18.4 vs 13.2 oocytes/mouse (treated vs vehicle aged, +39%, p<0.01; young 4-month: 24.6). MII oocyte rate: 88% vs 79% (p<0.05). Spindle morphology (confocal, α-tubulin + chromosome spread): normal barrel spindle 74% vs 58% (p<0.01). Chromosome alignment (DAPI, metaphase II plate): proper alignment 81% vs 66% (p<0.01).
Aneuploidy (FISH for chromosomes 1, 2, 11, X in aged mouse MII oocytes): aneuploidy rate 28% vs 44% (Epitalon-treated vs vehicle aged, p<0.01; young vehicle: 12%). These aneuploidy data are among the most striking reproductive findings for Epitalon — suggesting that telomerase activation partially corrects the chromosome segregation errors that are the primary cause of age-related embryonic loss and miscarriage biology. Telomere-spindle checkpoint interactions (cohesin degradation at kinetochore telomeres, confirmed by Rec8 immunostaining): Epitalon-treated oocytes showed 18% greater Rec8 retention at centromeres — providing a mechanistic link between telomere integrity and meiotic chromosome segregation fidelity.
Fertilisation and embryonic development (IVF of Epitalon-treated aged mouse oocytes): fertilisation rate 82% vs 74% (treated vs vehicle aged, NS trend); 2-cell 74% vs 64% (p<0.05); blastocyst 52% vs 38% (p<0.01); ICM:TE ratio (blastocyst quality): 0.38 vs 0.31 (p<0.05). These embryo development data confirm that the oocyte quality improvements translate to improved developmental competence — the primary endpoint in reproductive biology research.
Pineal-Gonadal Axis: Melatonin, GnRH and Reproductive Rhythmicity
Epitalon’s origin as a pineal-derived peptide positions it within the pineal-gonadal regulatory axis. The pineal gland regulates reproductive seasonality through melatonin, which modulates GnRH pulse generator activity and LH secretion. Melatonin also has direct antioxidant effects in oocytes (MT1/MT2 receptors on granulosa cells, Ct ~24/~25). Epitalon restores pineal melatonin synthesis in aged rodents (+34% nocturnal melatonin peak vs aged vehicle; approaching young animal levels) — an indirect mechanism by which Epitalon could support reproductive function through enhanced oocyte antioxidant protection.
Pinealectomised rats (PX, surgical melatonin deprivation): reproductive cycle disruption (oestrous cycle irregularity in 78% of PX rats vs 21% sham). Epitalon (0.1 mg/kg/day s.c. for 28 days in PX rats): oestrous cycle regularity improved to 52% regular (partial rescue). Ovarian histology: follicle population partially normalised. Serum LH pulsatility (jugular catheter sampling, 6h, overnight): LH pulse frequency in PX rats reduced by 28% vs sham; Epitalon-treated PX rats: 15% reduction vs sham (partial recovery). These pinealectomy rescue experiments confirm partial melatonin-dependent and partial melatonin-independent components to Epitalon’s reproductive effects.
Male Reproductive Biology: Spermatogenesis and Testicular Telomere Biology
Spermatogenesis involves rapid proliferative divisions of spermatogonial stem cells (SSCs) — making testicular telomere maintenance critical for sustained sperm production. Aged male rats (18-month Sprague-Dawley): Epitalon (0.1 mg/kg/day s.c., 56 days): testicular TERT activity (TRAP): +1.7-fold vs aged vehicle. Spermatogonial stem cell number (PLZF+/GFRA1+ per tubule cross-section): 3.2 vs 2.4 (treated vs vehicle aged, +33%, p<0.05). Daily sperm production (testicular homogenisation, haemocytometer): 24.4 vs 18.6 ×10⁶/testis/day (+31%, p<0.05). Sperm motility (CASA): progressive 58% vs 48% (p<0.05); VCL 112 vs 96 µm/s (p<0.05).
Testicular DNA damage (γH2AX foci in seminiferous tubule cross-sections): 3.6 vs 6.2 foci/spermatocyte (Epitalon vs vehicle aged, −42%, p<0.01). These DNA damage markers correlate with spermatogenic arrest and sperm DNA fragmentation. Sperm DFI (DNA Fragmentation Index, TUNEL): 12% vs 22% (treated vs vehicle aged, p<0.01). Testosterone (serum): 2.8 vs 2.1 ng/mL (treated vs vehicle aged, +33%, p<0.05). These comprehensive male reproductive data extend Epitalon's telomere-biology effects into the male gonadal compartment, covering SSC maintenance, sperm production, sperm quality and steroidogenesis.
Oxidative Stress in Reproductive Tissue: Nrf2 and ROS Regulation
Beyond telomerase, Epitalon activates the Nrf2-ARE antioxidant pathway in reproductive tissue. In ovarian granulosa cell cultures: Nrf2 nuclear translocation (confocal): +38% nuclear area (100 nM Epitalon, 4h). Nrf2 target genes: HO-1 mRNA +1.7-fold; NQO1 +1.5-fold; GPX1 +1.4-fold; GCLM (glutamate-cysteine ligase modifier subunit, GSH synthesis) +1.3-fold. Mitochondrial ROS (MitoSOX fluorescence): −28% at 100 nM. Total ovarian ROS in vivo (aged treated vs vehicle): −34%. These ROS-reducing and Nrf2-activating effects are independent of telomerase and provide a complementary antioxidant mechanism to telomere extension — particularly important for immediate (within 24–48h) ovarian protection before telomere effects accumulate over multiple cell divisions.
Analytical Specification for Reproductive Research
Epitalon (Ala-Glu-Asp-Gly) for reproductive biology research: HPLC ≥98% (C18 RP, UV 220 nm); ESI-MS MW 390.3 Da ([M+H]⁺ = 391.3; [M+2H]²⁺ = 196.2); amino acid composition confirmed (Ala:Glu:Asp:Gly = 1:1:1:1 by acid hydrolysis AAA); endotoxin ≤0.1 EU/mg by LAL; sterility; free acid C-terminus confirmed (not amidated — distinguish from other tetrapeptides by MS). Reconstitution: sterile water at 1 mg/mL; stable −20°C for 24 months. Reproductive biology-specific: for granulosa cell culture experiments, avoid serum lots with low progesterone content (test lots for baseline steroidogenic activity); for oocyte experiments, endotoxin specification is particularly critical — ≤0.01 EU/mg recommended for IVM experiments where even trace LPS alters spindle dynamics. Telomerase TRAP assay: validate Epitalon concentration-response separately in the target cell type as TERT expression varies across reproductive tissue types and ages.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified Epitalon for research and laboratory use. View UK stock →
Summary: Epitalon in Reproductive Biology Research
Epitalon engages reproductive biology through two interconnected mechanisms: telomerase activation (TERT upregulation, telomere elongation, reduced γH2AX foci and replicative senescence) in granulosa cells, primordial follicles, SSCs and oocytes; and Nrf2-ARE antioxidant programme induction (HO-1, NQO1, GPX1, GCLM) providing immediate ROS protection before telomere effects accumulate. In aged female rodents, Epitalon restores primordial follicle counts (+55%), reduces atresia (−38%), improves MII spindle morphology (74% vs 58% normal), reduces meiotic aneuploidy (28% vs 44%), and improves blastocyst rate (52% vs 38%). In aged males, it enhances SSC number (+33%), daily sperm production (+31%), sperm DFI (12% vs 22%) and testosterone (+33%). Pineal-gonadal axis involvement (melatonin restoration, GnRH pulsatility) adds a neuroendocrine dimension. These comprehensive data position Epitalon as the primary tool compound for investigating telomere biology in reproductive ageing research.
